Allergan Drops Part Of IBS Drug Patent Suit Against MSN
Drug maker Allergan has largely dropped its patent infringement claims against competitor MSN Pharmaceuticals over a generic version of Allergan's bowel treatment drug Viberzi, according to a Thursday filing....To view the full article, register now.
Already a subscriber? Click here to view full article